Author

J. E. Wilson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1 Cell Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:human· 3 Research Focus:cell type annotation· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Assay:ChIP-seq· 1 Research Focus:chromatin & epigenetic regulation· 1

Frequent Co-Authors

A. Bommi-Reddy· 1 shared A. Conery· 1 shared A. Hingway· 1 shared A. Maynard· 1 shared A. Poleshko· 1 shared D. A. Hafler· 1 shared D. Kim· 1 shared D. N. Mayhew· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Bommi-Reddy

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Oral Streptococci S. anginosus and S. mitis induce distinct morphological, inflammatory, and metabolic signatures in macrophages

M. D. L. Johnson, S. Senthilkumar, V. Gunda, D. Reinartz, K. Pond, P. V. Santiago Raj, J. E. Wilson

This study compares the effects of S. anginosus and S. mitis on macrophage inflammation and metabolism, finding S. anginosus induces stronger proinflammatory responses and unique metabolic changes.

bioRxiv · Aug 28, 2023 · PreprintMicrobiology

Microfluidic immuno-serology assay revealed a limited diversity of protection against COVID-19 in patients with altered immunity

D. Kim, G. Biancon, Z. Bai, J. VanOudenhove, Y. Liu, S. Kothari, L. Gowda, J. M. Kwan, N. C. Buitrago-Pocasangre, N. Lele, H. Asashima, M. K. Racke, J. E. Wilson, T. S. Givens, M. M. Tomayko, , R. Fan

The paper develops a microfluidic immuno-serology assay to analyze immune responses in patients with altered immunity, finding reduced diversity in protein cooperation and impaired antibody responses in certain groups.

bioRxiv · Aug 31, 2022 · PreprintBioengineering

CREBBP/EP300 acetyltransferase inhibition disrupts FOXA1-bound enhancers to inhibit the proliferation of ER+ breast cancer cells

A. Conery, A. Bommi-Reddy, S. Park-Chouinard, D. N. Mayhew, E. Terzo, A. Hingway, M. J. Steinbaugh, J. E. Wilson, R. J. Sims

This study shows that inhibiting CREBBP/EP300 acetyltransferase suppresses ER+ breast cancer growth by disrupting FOXA1-bound enhancers, offering a new therapeutic strategy.

bioRxiv · Dec 26, 2021Cancer Biology

The PRR14 heterochromatin tether encodes modular domains that mediate and regulate nuclear lamina targeting

K. L. Dunlevy, V. Medvedeva, J. E. Wilson, M. Hoque, T. Pellegrin, A. Maynard, M. M. Kremp, J. S. Wasserman, A. Poleshko, R. A. Katz

This study identifies a modular nuclear lamina binding domain in PRR14 that mediates heterochromatin anchoring and is regulated by phosphorylation and a PP2A phosphatase site.

bioRxiv · Oct 8, 2019Cell Biology